Q4 2025. Management View. CEO Cameron Reynolds said Q4 2025 included “our first order for the new Nu.Q Cancer assays for clinical certi ...
A startup hub planned for the old Navy Base boasts of green “deep tech”— but experts warn some of that tech only provides ...
Q4 2025 earnings call recap: 2026 revenue guidance, CompuFlo growth, margin outlook, and 2027 breakeven goal—read now.
Syntholene Energy Corp. (TSXV: ESAF) (FSE: 3DD0) (OTCQB: SYNTF) ("Syntholene" or the "Company") announces that it has entered into an advisory agreement (the "Liquidity Services Agreement") with DS ...
Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced the expansion of its Board of ...
INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations.
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2025 Earnings Call Transcript March 27, 2026 Autolus Therapeutics plc misses on ...
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence ("AI”) to develop ...
Elon Musk's SpaceX confidentially filed for what could be a record-breaking U.S. listing, a person familiar with the matter ...
Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...
PHOENIX & SANTA FE, N.M.-- (BUSINESS WIRE)--April 1, 2026-- ...
PITTSBURGH, PA, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- Alyssa S. of Chatham, MA is the creator of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results